Download het volledig rapport (302 p.) - KCE

KCE reports vol. 6A Prenatale zorg 263
58. Carroli G, Villar J, Piaggio G, et al. WHO systematic review of
randomised controlled trials of routine antenatal care. Lancet 2001;
357(9268): 1565-1570.
59. Petrou S, Kupek E, Vause S, et al. Antenatal visits and adverse perinatal
outcomes: results from a British population-based study. Eur J Obstet
Gynecol Reprod Biol 2003; 106(1): 40-49.
60. Hildingsson I, Waldenstrom U, Radestad I. Women's expectations on
antenatal care as assessed in early pregnancy: number of visits, continuity
of caregiver and general content. Acta Obstet Gynecol Scand 2002;
81(2):118-125.
61. World Health Organization (WHO). Antenatal Care: report of a
Technical Working Group. WHO: Geneva, Switzerland. 1996.
62. Rosenberg TJ, Garbers S, Chavkin W, et al. Prepregnancy weight and
adverse perinatal outcomes in an ethnically diverse population. Obstet
Gynecol 2003; 102(5): 1022-1027.
63. Jensen DM, Damm P, Sorensen B, et al. Pregnancy outcome and
prepregnancy body mass index in 2459 glucose-tolerant Danish women.
Am J Obstet Gynecol 2003; 189: 239-44.
64. Gulbis B, Tshilolo L, Cotton F, et al. Newborn screening for
haemoglobinopathies: the Brussels experience. J Med Screen 1999; 6(1):
11-5.
65. Donders GG. Surveillance of infection during pregnancy: the boundary
between routine screening and symptom-driven diagnosis. Thesis
Doctor in de Medische Wetenschappen . Katholieke Universiteit
Leuven 1997.
66. Honest H, Bachmann LM, Knox EM, et al. The accuracy of various tests
for bacterial vaginosis in predicting preterm birth: a systematic review.
BJOG 2004; 111(5): 409-22.
67. Guaschino S, Ricci E, Franchi M, et al. Treatment of asymptomatic
bacterial vaginosis to prevent pre-term delivery: a randomised trial. Eur J
Obstet Gynecol Reprod Biol 2003; 110: 149-152.
68. Ugwumadu A, Manyonda I, Reid F, et al. Effect of early clindamycin on
late miscarriage and preterm delivery in asymptomatic women with
abnormal vaginal flora and bacterial vaginosis: a randomised controlled
trial. Lancet 2003; 361: 983-88.
69. Klebanoff M, Hauth J, MacPherson C, et al. Time course of the regression
of asymptomatic bacterial vaginosis in pregnancy with and without
treatment. Am J Obstet Gynecol 2003; 190: 363-70.
70. Kekki M, Kurki T, Kotomäki T, et al. Cost-effectiveness of screening and
treatment for bacterial vaginosis in early pregnancy among women at low
risk for preterm birth. Acta Obstet Gynecol Scand 2004; 83: 27-36.
71. Defraye A, Sasse A. SOA surveillancesysteem via een peilnetwerk van
clinici in België. Resultaten van de derde registratie periode oktober 2002
januari 2003. (http://www.iph.fgov.be/epidemio/epinl/aidsnl/mst03-nl.pdf)
72. Watson E, Templeton A, Russell I, et al. The accuracy and efficacy of
screening tests for chlamydia trachomatis: a systematic review. J Med
Microbiol 2002; 51: 1021-1031.
73. Moore M, Schrag J, Schuchat A. Effects of intrapartum antimicrobial
prophylaxis for prevention of group-B-streptococcal disease on the
incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis
2003; 3: 201-13.